These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 22589591)
1. Role of scintimammography in the diagnosis of breast cancer. Das BK; Biswal BM; Bhavaraju M Malays J Med Sci; 2006 Jan; 13(1):52-7. PubMed ID: 22589591 [TBL] [Abstract][Full Text] [Related]
2. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography. Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524 [TBL] [Abstract][Full Text] [Related]
3. 99m Tc-sestamibi scintimammography in detection of recurrent breast cancer. Rajkovaca Z; Vuleta G; Matavulj A; Kovacević P; Ponorac N Bosn J Basic Med Sci; 2007 Aug; 7(3):256-60. PubMed ID: 17848153 [TBL] [Abstract][Full Text] [Related]
4. Comparison of accuracy of scintimammography and X-ray mammography in the diagnosis of primary breast cancer in patients selected for surgical biopsy. Cwikla JB; Buscombe JR; Kelleher SM; Parbhoo SP; Thakrar DS; Hinton J; Deery AR; Crow J; Hilson AJ Clin Radiol; 1998 Apr; 53(4):274-80. PubMed ID: 9585043 [TBL] [Abstract][Full Text] [Related]
5. Positive predictive value of 99mTc sestamibi scintimammography in patients with non-palpable, mammographically detected, suspicious, breast lesions. Lumachi F; Zucchetta P; Marzola MC; Ferretti G; Povolato M; Paris MK; Brandes AA; Bui F Nucl Med Commun; 2002 Nov; 23(11):1073-8. PubMed ID: 12411835 [TBL] [Abstract][Full Text] [Related]
6. Scintimammographic analysis of nonpalpable breast lesions previously identified by conventional mammography. Tolmos J; Cutrone JA; Wang B; Vargas HI; Stuntz M; Mishkin FS; Diggles LE; Venegas RJ; Klein SR; Khalkhali I J Natl Cancer Inst; 1998 Jun; 90(11):846-9. PubMed ID: 9625173 [TBL] [Abstract][Full Text] [Related]
7. [Dosimetry in scintimammography by (99m)Tc-MIBI, (99m)Tc-Tetrofosmin, (99m)Tc-(V)DMSA and 201TlCl compared with X-rays mammography]. Lyra M; Vamvakas I Hell J Nucl Med; 2009; 12(2):184-8. PubMed ID: 19675881 [TBL] [Abstract][Full Text] [Related]
8. Breast Cancer Imaging: Can Tc-99m Sestamibi Scintimammography Fit In? Iraniha S; Khalkhali I; Cutrone JA; Diggles L; Klein SR Medscape Womens Health; 1997 Apr; 2(4):2. PubMed ID: 9746689 [TBL] [Abstract][Full Text] [Related]
9. The role of 99mTc-sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis. Taillefer R Semin Nucl Med; 1999 Jan; 29(1):16-40. PubMed ID: 9990681 [TBL] [Abstract][Full Text] [Related]
10. Tc-99m-tetrofosmin scintimammography: a prospective study in primary breast lesions. Lind P; Gallowitsch HJ; Kogler D; Kresnik E; Mikosch P; Gomez I Nuklearmedizin; 1996 Dec; 35(6):225-9. PubMed ID: 8976502 [TBL] [Abstract][Full Text] [Related]
11. High-resolution scintimammography improves the accuracy of technetium-99m methoxyisobutylisonitrile scintimammography: use of a new dedicated gamma camera. Scopinaro F; Pani R; De Vincentis G; Soluri A; Pellegrini R; Porfiri LM Eur J Nucl Med; 1999 Oct; 26(10):1279-88. PubMed ID: 10541826 [TBL] [Abstract][Full Text] [Related]
12. Scintimammography using Tc-99m tetrofosmin. Lind P; Umschaden HW; Forsthuber E; Oman J; Kerschbaumer K; Gallowitsch HJ; Mikosch P; Kresnik E; Molnar M; Gomez I Acta Med Austriaca; 1997; 24(2):50-4. PubMed ID: 9227787 [TBL] [Abstract][Full Text] [Related]
13. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up. Khalkhali I; Cutrone J; Mena I; Diggles L; Venegas R; Vargas H; Jackson B; Klein S J Nucl Med; 1995 Oct; 36(10):1784-9. PubMed ID: 7562043 [TBL] [Abstract][Full Text] [Related]
14. Role of 99mTc-MIBI scintimammography and X-ray mammography in the diagnosis of locoregional recurrence of breast cancer. Usmani S; Niaz K; Maseeh-Uz-Zaman ; Kamal S; Niyaz K; Mehboob J; Hashmi A; Habib S; Hashmi H J Pak Med Assoc; 2007 Apr; 57(4):172-5. PubMed ID: 17489522 [TBL] [Abstract][Full Text] [Related]
15. Technetium-99m sestamibi scintimammography complements mammography in the detection of breast cancer. Krishnaiah G; Sher-Ahmed A; Ugwu-Dike M; Regan P; Singer J; Totoonchie A; Spiegler E; Sardi A Breast J; 2003; 9(4):288-94. PubMed ID: 12846862 [TBL] [Abstract][Full Text] [Related]
16. Can scintimammography with (99m)Tc-MIBI identify multifocal and multicentric primary breast cancer? Cwikla JB; Buscombe JR; Holloway B; Parbhoo SP; Davidson T; McDermott N; Hilson AJ Nucl Med Commun; 2001 Dec; 22(12):1287-93. PubMed ID: 11711898 [TBL] [Abstract][Full Text] [Related]
17. International prospective evaluation of scintimammography with technetium-99m sestamibi: interim results. Sampalis FS; Denis R; Picard D; Fleiszer D; Martin G; Nassif E; Sampalis JS Am J Surg; 2001 Oct; 182(4):399-403. PubMed ID: 11720679 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of mammographic breast lesions with Tc-99m sestamibi scintimammography and contrast enhanced MRI. Sommer H; Tiling R; Pechmann M; Kindermann G; Kress K; Moser R; Tatsch K; Hahn K; Pfluger T; Assemi C Zentralbl Gynakol; 1997; 119(1):6-11. PubMed ID: 9050197 [TBL] [Abstract][Full Text] [Related]
20. The role of technetium-99m methoxyisobutylisonitrile scintimammography in diagnosis of breast cancer in patients with mammographically dense breasts. Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH Anticancer Res; 2000; 20(5C):3755-8. PubMed ID: 11268450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]